Michael Derby - 13 Apr 2023 Form 4 Insider Report for PaxMedica, Inc.

Role
Executive Chairman, Director, 10%+ Owner
Signature
/s/ Stephen D. Sheldon, Jr. Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
13 Apr 2023
Net transactions value
$0
Form type
4
Filing time
14 Apr 2023, 19:11:22 UTC
Previous filing
09 Mar 2023
Next filing
28 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PXMD Common Stock Award $0 +150,000 +46% $0.000000 474,430 13 Apr 2023 Direct F1
holding PXMD Common Stock 7,336,745 13 Apr 2023 TardiMed Sciences, LLC F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of 150,000 restricted stock units ("RSUs"). The RSUs are subject to time-based vesting with one-third of the RSUs vesting on February 1, 2024, followed by 8.3325% of the remaining RSUs vesting on a quarterly basis thereafter, subject to the reporting person's continuous employment with the Company as of such vesting dates.
F2 The reporting person is the Managing Partner of TardiMed and has sole voting and dispositive control over the shares of Common Stock held by the entity. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.